Advances in the development of new biomarkers for Alzheimer’s disease

Alzheimer's disease (AD) is a complex, heterogeneous, progressive disease and is the most common type of neurodegenerative dementia. The prevalence of AD is expected to increase as the population ages, placing an additional burden on national healthcare systems. There is a large need for new di...

Descripción completa

Detalles Bibliográficos
Autores principales: Klyucherev, Timofey O., Olszewski, Pawel, Shalimova, Alena A., Chubarev, Vladimir N., Tarasov, Vadim V., Attwood, Misty M., Syvänen, Stina, Schiöth, Helgi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027827/
https://www.ncbi.nlm.nih.gov/pubmed/35449079
http://dx.doi.org/10.1186/s40035-022-00296-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027827/
https://www.ncbi.nlm.nih.gov/pubmed/35449079
http://dx.doi.org/10.1186/s40035-022-00296-z

Ejemplares similares